Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 189

Results For "Research"

2102 News Found

Syngene revenue from operations up 17 per cent in Q2FY22
News | October 21, 2021

Syngene revenue from operations up 17 per cent in Q2FY22

The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations


NIH grants in-principle accreditation to Advanced Enzymes supplements
Healthcare | October 20, 2021

NIH grants in-principle accreditation to Advanced Enzymes supplements

The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness


Domestic growth to the fore as US weakness persists: ICICI Direct
News | October 19, 2021

Domestic growth to the fore as US weakness persists: ICICI Direct

ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report


Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline
Biotech | October 18, 2021

Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline

Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme


Resilience and Harvard announce five-year R&D alliance
News | October 18, 2021

Resilience and Harvard announce five-year R&D alliance

First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders


Expect normal quarter in Q2FY22: Emkay
News | October 15, 2021

Expect normal quarter in Q2FY22: Emkay

Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report


Exelixis in-licenses second anti-cancer compound from Aurigene
Biotech | October 15, 2021

Exelixis in-licenses second anti-cancer compound from Aurigene

U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma


AUM Biosciences closes US $ 27 million `Series A’ funding round
Startup | October 15, 2021

AUM Biosciences closes US $ 27 million `Series A’ funding round

Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate


Smith’s Detection confirms BioFlash detects airborne Covid-19
Medical Device | October 14, 2021

Smith’s Detection confirms BioFlash detects airborne Covid-19

It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis


Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis
Biotech | October 14, 2021

Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis

Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations